The Max Delbrück Center in the Helmholtz Association (MDC) has informed the Berlin State Office for Health and Social Affairs (LaGeSo) of the number of test animals it used in 2015, which has changed only slightly in comparison to 2014. A total of 40,121 animals were used and killed in the course of experimental research […]
Archives for Insights Team
Berlin, April 20, 2016. Today, Vice-Minister of the Economy of the Republic of Lithuania Marius Skarupskas visited the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) and the Berlin-Buch campus, accompanied by some of Lithuania’s leading business and science experts.
A joint press release by the Max Delbrück Center for Molecular Medicine (MDC), Charité – Universitätsmedizin Berlin, and the Berlin Institute of Health (BIH) From 2017, a new building will be constructed on the Berlin-Buch research campus that will unite several institutions under one roof. The Max Delbrück Center for Molecular Medicine (MDC) and Charité […]
Press release of the Rudolf-Virchow-Zentrum of the Universität Würzburg. International scientists led by Carsten Hoffmann and Martin Lohse identified for the first time β-Arrestin as an independent signaling molecule. The protein modulates a pharmaceutically important pathway and leads to new drug targets, for example in pain therapy.
More than 200 high school students explore the world of stem cells. On March 11, 2016 stem cells were on the timetable for a number of students in Berlin with a keen interest in biology. More than 200 high school students from 15 Berlin schools attended Germany’s first UniStem Day, hosted by the Max Delbrück […]
The Supervisory Board of the Max Delbrück Center for Molecular Medicine of the Helmholtz Association (MDC) has just named Prof. Martin Lohse as the new Chair of the Board and Scientific Director of the MDC. He will take office on April 1. “With the appointment of Martin Lohse we have gained a superb scientist who […]
World’s first patient-based cardiac MRI study using 7T MRI In a world-first, researchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine (MDC) have performed cardiac MRI imaging using a 7T MRI scanner in a patient-based study. 7T MRI imaging is a powerful new technology that allows high resolution images of […]
Citizen science: Teachers, pupils and scientists work together to measure sitting behavior in young people We all know that a passive lifestyle is bad for our health – but the precise reasons why remain unclear. A group of scientists from the Max Delbrück Center for Molecular Medicine (MDC) has now teamed up with teachers and […]
Human stem cells that are capable of becoming any other kind of cell in the body have previously only been acquired and cultivated with difficulty. Scientists at the Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association have now presented details of a method to detect such pluripotent cells in a cell culture […]
“VONVENDI [von Willebrand factor (Recombinant)]”, the new drug from Baxalta Incorporated, a global biopharmaceutical company recently spun off from Baxter International, has just been approved by the United States Food and Drug Administration. It is the first, and so far the only, recombinant protein for the treatment of von Willebrand disease, and offers those affected […]